Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
4.7%
1w
5.0%
1m
8.0%
3m
21.0%
6m
37.4%
1y
58.4%
all
81.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,989 4.7%
1,572
2,658
Company Overview
Sales
1,086 Cr
Growth: 14.8%
Profit after Tax
328 Cr
Growth: 4.7%
Mid Cap
20,803 Cr
P/E: 63.5x
Industry P/E: 35.6x
Fundamentals
Sales (Cr) ₹ 1,086
Growth 14.8%
EBITDA 42.2%
P/S 19.2x
Dividend 0.0%
P/E 63.5x
Book Value ₹ 161
PEG Ratio 4.3x
ROE 20.8%
P/B 12.4x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (14 Indices) view more